(34)Commission Implementing Regulation (EU) 2024/324note extended the approval period of the active substance fluazinam until 15 April 2026, and the approval period of the active substance fluopyram until 30 June 2026.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.